Baxter International Inc. (BAX)

US — Healthcare Sector
Peers: MASI  MDGL  ATR  RGEN  RNA  AVTR  DVA  HIMS  BIO  QGEN 

Automate Your Wheel Strategy on BAX

With Tiblio's Option Bot, you can configure your own wheel strategy including BAX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baxter International, Inc. of Class Action Lawsuit and Upcoming Deadlines - BAX
BAX
Published: October 30, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Baxter International, Inc. of Class Action Lawsuit and Upcoming Deadlines - BAX
Baxter International (BAX) Beats Q3 Earnings Estimates
BAX
Published: October 30, 2025 by: Zacks Investment Research
Sentiment: Positive

Baxter International (BAX) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.8 per share a year ago.

Read More
image for news Baxter International (BAX) Beats Q3 Earnings Estimates
Levi & Korsinsky Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 – BAX
BAX
Published: October 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Company") (NYSE: BAX) of a class action securities lawsuit.

Read More
image for news Levi & Korsinsky Reminds Baxter International, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 – BAX
Law Offices of Frank R. Cruz Encourages Baxter International, Inc. (BAX) Shareholders to Inquire About Securities Fraud Class Action
BAX
Published: October 28, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Baxter International, Inc. (BAX) Shareholders To Inquire About Securities Fraud Class Action.

Read More
image for news Law Offices of Frank R. Cruz Encourages Baxter International, Inc. (BAX) Shareholders to Inquire About Securities Fraud Class Action
Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?
BAX
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive

Baxter's Q3 results are expected to show steady revenue growth led by Advanced Surgery and Drug Compounding, though IV fluid and anesthesia softness may weigh on EPS.

Read More
image for news Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
BAX
Published: October 28, 2025 by: PRNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 28, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. ("Baxter" or the …

Read More
image for news SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Baxter International, Inc. (BAX) Shareholders To Inquire About Securities Fraud Class Action
BAX
Published: October 27, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plaintiff motion. IF YOU SUFFERED A LOSS.

Read More
image for news Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Baxter International, Inc. (BAX) Shareholders To Inquire About Securities Fraud Class Action
BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline
BAX
Published: October 27, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Baxter International Inc. (NYSE: BAX)? Did you purchase your shares between February 23, 2022 and July 30, 2025, inclusive?

Read More
image for news BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline
BAX INVESTOR NOTICE: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
BAX
Published: October 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., No. 25-cv-12672 (N.D. Ill.), the Baxter class action lawsuit charges Baxter as well as certain of Baxter's top current and former executives with violations of the Securities Exchange Act of …

Read More
image for news BAX INVESTOR NOTICE: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
BAXTER CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Baxter International Stockholders to Contact the Firm Regarding Filed Class Action Lawsuit
BAX
Published: October 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Baxter (BAX) To Contact Him Directly To Discuss Their Options If you purchased or Baxter common stock between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

Read More
image for news BAXTER CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Baxter International Stockholders to Contact the Firm Regarding Filed Class Action Lawsuit
Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm
BAX
Published: October 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) for violations of the federal securities laws on behalf of investors who purchased or acquired Baxter securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

Read More
image for news Lowey Dannenberg Notifies Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $250,000 in Losses to Contact the Firm
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
BAX
Published: October 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

LOS ANGELES, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 15, 2025.

Read More
image for news BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
BAX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
BAX
Published: October 23, 2025 by: PRNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. ("Baxter" or the …

Read More
image for news BAX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Portnoy Law Firm Announces Class Action on Behalf of Baxter International, Inc. Investors
BAX
Published: October 23, 2025 by: GlobeNewsWire
Sentiment: Neutral

LOS ANGELES, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Baxter International, Inc., (“Baxter” or the "Company") (NYSE: BAX) investors off a class action on behalf of investors that bought securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”). Baxter investors have until December 15, 2025 to file a lead plaintiff motion.

Read More
image for news Portnoy Law Firm Announces Class Action on Behalf of Baxter International, Inc. Investors
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
BAX
Published: October 22, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , Oct. 22, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

Read More
image for news BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BAX
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., No. 25-cv-12672 (N.D. Ill.), the Baxter.

Read More
image for news BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BAX INVESTOR ALERT: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BAX
Published: October 20, 2025 by: PRNewsWire
Sentiment: Neutral

SAN DIEGO , Oct. 20, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period"), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W.

Read More
image for news BAX INVESTOR ALERT: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BAX CLASS ACTION LAWSUIT: Baxter International Inc. Shipping Pauses Trigger Securities Fraud Class Action after Stock Plummets 22% -- Investors Urged to Contact BFA Law
BAX
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Baxter International Inc. (NYSE: BAX) and certain of the Company's senior executives for securities fraud after significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Baxter, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/baxter-international-inc-class-action.

Read More
image for news BAX CLASS ACTION LAWSUIT: Baxter International Inc. Shipping Pauses Trigger Securities Fraud Class Action after Stock Plummets 22% -- Investors Urged to Contact BFA Law
BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.
BAX
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025. Baxter is a global company that develops, manufactures, and markets medical products used in hospitals and other healthcare facilities.

Read More
image for news BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.
Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX
BAX
Published: October 20, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)--Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX.

Read More
image for news Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BAX
Published: October 20, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , Oct. 20, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or "the Company") (NYSE: BAX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Baxter securities between February 23, 2023 and July 30, 2025, both dates inclusive (the "Class Period").

Read More
image for news BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
BAX
Published: October 17, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)---- $BAX #BAX--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The.

Read More
image for news DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Baxter International, Inc. (BAX)
BAX
Published: October 17, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of all persons or entities who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).

Read More
image for news Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Baxter International, Inc. (BAX)
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
BAX
Published: October 17, 2025 by: Business Wire
Sentiment: Neutral

LOS ANGELES--(BUSINESS WIRE)---- $BAX--BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm.

Read More
image for news BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
BAX
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive

BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.

Read More
image for news Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
Is Now The Time To Buy Baxter Stock?
BAX
Published: August 26, 2025 by: Forbes
Sentiment: Negative

Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year guidance, partly due to Hurricane Helene impacting one of its manufacturing facilities.

Read More
image for news Is Now The Time To Buy Baxter Stock?
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
BAX, JNJ, MDT
Published: August 01, 2025 by: Benzinga
Sentiment: Positive

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Read More
image for news Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
BAX
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Negative

Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.

Read More
image for news Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
BAX
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Negative

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

Read More
image for news BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
BAX
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Neutral

Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawrence H.

Read More
image for news Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript

About Baxter International Inc. (BAX)

  • IPO Date 1981-10-27
  • Website https://www.baxter.com
  • Industry Medical - Instruments & Supplies
  • CEO Andrew Hider
  • Employees 38000

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.